Mina C. Hosseinipour is the Scientific Director of the University of North Carolina (UNC) Project in Lilongwe, Malawi and Professor of Medicine at UNC-Chapel Hill School of Medicine. Since 2001, she has been based in Lilongwe, Malawi where she leads research efforts in HIV treatment and prevention through several NIH-sponsored research networks (AACTG, HPTN, HVTN, IMPAACT, and MTN). Her research also has focused on improving operations within the Malawi antiretroviral program. Currently, her primary research focus includes biologic prevention strategies such as the use of injectable pre-exposure prophylaxis (PrEP), antibody-mediated prevention (AMP), HIV vaccines, and treatment as prevention. Alongside this prevention portfolio, she is focused on locating and working with populations at higher risk of HIV exposure who could benefit from tailored HIV prevention services and models for prevention care delivery.